ICU Map
cardiovascular / hemodynamic

Acute Severe Hypertension & Hypertensive Emergencies

Differentiating hypertensive emergency (acute target organ damage) from asymptomatic hypertension: tailored pressure targets for SCAPE, aortic dissection, hemorrhagic stroke, and ischemic stroke.

Acute severe blood pressure elevation (typically SBP > 180 mmHg or DBP > 110–120 mmHg) requires immediate clinical differentiation between a Hypertensive Emergency (evidence of acute, progressive target organ damage) and Hypertensive Urgency / Asymptomatic Hypertension. In a hypertensive emergency, immediate parenteral blood pressure lowering is required, but the speed, depth, and choice of agent depend strictly on the specific organ system at risk.

Caution

Dangerous Diagnosis Not to Miss: Acute Aortic Dissection (Type A/B), Acute Intracranial Hemorrhage (ICH/SAH), Sympathetic Crashing Acute Pulmonary Edema (SCAPE), Acute Myocardial Infarction, Hypertensive Encephalopathy / Posterior Reversible Encephalopathy Syndrome (PRES), and Eclampsia.

CLINICAL ALGORITHMMedically Verified (2026-09-16)

Acute hypertensive pulmonary edema: oxygenate, unload, avoid crashing the ventricle

Figure: Acute hypertensive pulmonary edema: oxygenate, unload, avoid crashing the ventricle. This action-focused visual summarizes the linked Clinical Problem; the full problem text, evidence references and local policy remain the source of truth.(Action pathway — use the full evidence-linked problem and local protocol for clinical decisions)
1

RECOGNIZE & TARGET ORGAN DAMAGE SCREEN

  • Neurologic Screen: Severe headache, altered mental status, seizures, visual loss (papilledema), focal deficits -> CT head (ICH, ischemic stroke, PRES).

  • Cardiovascular Screen: Tearing chest/back pain (aortic dissection), ischemic chest discomfort (ACS), dyspnea/orthopnea (flash pulmonary edema) -> ECG, troponin, chest X-ray/CTA.

  • Renal Screen: Acute oliguria, hematuria, rising creatinine -> UA, creatinine, electrolytes.

  • Obstetric Screen: Pregnancy > 20 weeks with hypertension, headache, epigastric pain -> check preeclampsia labs (platelets, LFTs, urine protein).

2

ORGAN-SPECIFIC BLOOD PRESSURE TARGETS

  • Acute Aortic Dissection: Ultra-rapid lowering within 20 minutes:

    • Heart Rate Target: HR 60–80 bpm with IV Esmolol or Labetalol as initial anti-impulse therapy (unless contraindicated) to reduce aortic wall shear stress (dP/dt).
    • Blood Pressure Target: SBP < 120 mmHg (add Nicardipine or Nitroprusside only AFTER beta-blockade to prevent reflex tachycardia).

  • Sympathetic Crashing Acute Pulmonary Edema (SCAPE):

    • Use early NIV plus rapidly titrated IV nitroglycerin when marked hypertension and pulmonary edema physiology support it. High-dose bolus regimens are protocol-specific/off-label; titrate to symptoms and hemodynamics rather than a universal 20–30% target.

  • Acute Intracerebral Hemorrhage (ICH):

    • Target: Smoothly lower SBP to 130–140 mmHg within hours (avoid SBP < 130 mmHg) using IV Nicardipine or Clevidipine.

  • Acute Ischemic Stroke (Candidate for Thrombolysis/Thrombectomy):

    • Pre-tPA Target: SBP < 185 mmHg and DBP < 110 mmHg.
    • Post-tPA Target: SBP < 180 mmHg and DBP < 105 mmHg for at least 24 hours.

  • Acute Ischemic Stroke (Non-Reperfusion Candidate):

    • Permissive Hypertension: Lower blood pressure ONLY if SBP > 220 mmHg or DBP > 120 mmHg (modest 15% reduction in 24h to avoid expanding cerebral ischemic penumbra).
3

FIRST-LINE PARENTERAL ANTIHYPERTENSIVE AGENTS

  • IV Nicardipine: DHP calcium channel blocker; start 5 mg/hr, titrate by 2.5 mg/hr q5–15m (max 15 mg/hr); predictable, preserves cerebral autoregulation.

  • IV Clevidipine: Ultra-short-acting lipid emulsion CCB; start 1–2 mg/hr, double q90s (max 32 mg/hr); ideal for rapid micro-titration.

  • IV Labetalol: Combined alpha-1 and non-selective beta-blocker (1:7 ratio); 10–20 mg IV bolus over 2 min, repeated q10m (or infusion 1–8 mg/min); avoid in severe asthma, bradycardia, or acute decompensated heart failure.

  • IV Nitroglycerin: Predominant venodilator; high doses reduce afterload; drug of choice in SCAPE and ischemic ACS.

4

REASSESSMENT & ESCALATION

Caution

Common Diagnostic Trap: Overzealous, precipitous blood pressure reduction in acute ischemic stroke or chronic severe hypertension. Rapid drops shift cerebral perfusion below the autoregulatory plateau, converting viable ischemic penumbral tissue into irreversible cerebral infarction.

Destination Topics

  • Cardiogenic Pulmonary Edema: SCAPE physiology and high-dose nitrate therapy.

  • Intracranial Hemorrhage: Blood pressure reduction targets, hematoma expansion, and reversal.

  • Ischemic Stroke: Permissive hypertension, post-thrombectomy perfusion, and rtPA criteria.

  • Intracranial Hypertension: Cerebral perfusion pressure (CPP = MAP - ICP) targets.

  • Acute Coronary Syndromes: Coronary perfusion pressure and afterload reduction.

Evidence status

Review metadata not yet recorded.

Status, review dates and guideline versions appear here once editorial metadata is authored for this content.

Actionable Clinical Workflows (5)

Step-by-step ICU Processes
Acute Hypoxemia

From confirming true hypoxemia to identifying the underlying mechanism.

Launch Workflow →
Initial Hemodynamic Resuscitation & Shock Bundling

From recognizing hypoperfusion and initial crystalloid bolus to dynamic fluid responsiveness assessment and vasopressor targets.

Launch Workflow →
Vasopressor & Inotrope Initiation & Titration

From first-line norepinephrine titration to multi-agent vasopressor escalation and inotrope selection.

Launch Workflow →
Acute Valvular Hemodynamic Collapse

Structured emergency bedside protocol from POCUS lesion differentiation to lesion-specific hemodynamics and surgical rescue.

Launch Workflow →

Deep-Dive Topic Destinations (7)

Reference Knowledge
Hypertensive Emergenciescardiovascular

Target organ damage assessment, intravenous antihypertensive titration, and emergency-specific blood pressure targets.

Explore Topic →
Acute Aortic Syndromescardiovascular

Emergency classification, anti-impulse medical stabilization, and surgical vs endovascular management of aortic dissection, intramural hematoma, and penetrating atherosclerotic ulcer.

Explore Topic →
Acute Cardiogenic Pulmonary Edema & SCAPEcardiovascular

Hydrostatic pulmonary edema physiology, SCAPE vs decompensated HF vs cardiogenic shock, NIV, titrated vasodilators when hypertensive, diuresis, and sequential nephron blockade.

Explore Topic →
Intracranial Hemorrhage: ICH & SAHneurology

Spontaneous ICH vs Aneurysmal SAH, INTERACT-2/ATACH-2 blood pressure targets, emergency anticoagulant reversal, ENRICH minimally invasive evacuation, ISAT coiling, and Nimodipine for delayed cerebral ischemia.

Explore Topic →
Acute Ischemic Strokeneurology

Core vs penumbra dynamics, ASPECTS & CT perfusion, Tenecteplase/Alteplase thrombolysis, DAWN/DEFUSE 3 extended thrombectomy, BP targets, and malignant MCA hemicraniectomy.

Explore Topic →
Intracranial Hypertension & Cerebral Edemaneurology

Monro-Kellie doctrine, ICP waveforms (P2>P1, Lundberg A-waves), CPP targets (60–70 mmHg), herniation syndromes, and the 4-tier BTF management protocol.

Explore Topic →
Acute Coronary Syndromecardiovascular

Plaque rupture, coronary thrombosis, STEMI vs NSTEMI risk stratification, emergent reperfusion, DAPT/anticoagulation, and mechanical/electrical ICU complications.

Explore Topic →